Bacillus coagulans is a species of lactic acid bacteria that naturally occurs in the guts of humans and animals. It helps maintain a healthy gastrointestinal tract by inhibiting the growth of harmful bacteria and promoting the growth of beneficial bacteria in the digestive system. Bacillus coagulans is commonly marketed as a probiotic supplement and is used in food and beverages products to improve gut health, support digestion and immune function. Some key uses of Bacillus coagulans products include supplements for IBS relief, digestive support, constipation relief, and acid reflux relief.

The global Bacillus Coagulans market is expected to witness high growth, exhibiting CAGR of 6.8% over the forecast period, due to increasing awareness about probiotic health benefits.

North America dominated the Bacillus Coagulans market in 2022 and accounted for over 30% of the global market share. This is attributed to rising health concerns and increased spending on probiotic supplements in the region. Asia Pacific is expected to be the fastest growing market during the forecast period owing to growing middle class population and their increasing disposable income in the region.

Key players operating in the Bacillus Coagulans market are Ganeden, Sabinsa Corporation, UAS Laboratories, Sanzyme, Mitsubishi Chemical Foods Corporation, Mystical Biotech Pvt. Ltd., Aumgene Biosciences, Unique Biotech Ltd., Nebraska Culture, and Syngem Biotech. Ganeden and Sabinsa Corporation collectively accounted for over 25% of the global market share in 2022.

Read More

https://healthcarelatesteditionnews.blogspot.com/2023/11/pharmaceuticals-is-largest-segment.html